Follow The Filings

AXTI AXT

AXT earnings company data as of 8:01 PM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 0.30 — —
Rev — — —

Insider trades

Open-market buys and sales by AXTI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AXTI insider trades
  • None no insider bought on the open market
  • $78.8M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Leonard J Leblanc Director
    Sale
    $221K 2,500 shares at $88.57 2.1% of stake
    Traded Jun 10–Aug 7 Filed Aug 19
    ↗
  2. Leonard J Leblanc Director
    Sale
    $384K 4,000 shares at $96.07 3.4% of stake
    Traded Aug 17 Filed Aug 19
    ↗
  3. Jesse Chen Director
    Sale
    $711K 6,172 shares at $115.24 11% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  4. David C Chang Director
    Sale
    $926K 8,333 shares at $111.17 11% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  5. Jesse Chen Director
    Sale
    $2M 22,000 shares at $92.82 28% of stake
    Traded Jun 11–12 Filed Jun 15
    ↗
  6. Jesse Chen Director
    Sale
    $1.5M 16,500 shares at $89.97 17% of stake
    Traded Jun 8–10 Filed Jun 10
    ↗
  7. Jesse Chen Director
    Sale
    $1.1M 10,133 shares at $109.50 9.7% of stake
    Traded Jun 3–4 Filed Jun 5
    ↗
  8. Morris S Young CEO
    Sale
    $22.3M 197,498 shares at $112.98 8.4% of stake
    Traded Jun 1–2 Filed Jun 3
    ↗
  9. Jesse Chen Director
    Sale
    $579K 5,200 shares at $111.36 4.7% of stake
    Traded Jun 1–2 Filed Jun 3
    ↗
  10. Jesse Chen Director
    Sale
    $700K 14,086 shares at $49.70 11% of stake
    Traded Mar 12–13 Filed Mar 16
    ↗
  11. Morris S Young CEO
    Sale
    $1.9M 37,905 shares at $51.13 1.6% of stake
    Traded Mar 13 Filed Mar 16
    ↗
  12. Gary L Fischer CFO
    Sale
    $4.5M 89,032 shares at $50.60 32% of stake
    Traded Mar 12–13 Filed Mar 16
    ↗
  13. Morris S Young CEO
    Sale
    $1.4M 30,832 shares at $45.60 1.3% of stake
    Traded Mar 10 Filed Mar 12
    ↗
  14. David C Chang Director
    Sale
    $920K 20,000 shares at $46.00 22% of stake
    Traded Mar 10 Filed Mar 12
    ↗
  15. Jesse Chen Director
    Sale
    $1.4M 29,000 shares at $46.66 19% of stake
    Traded Mar 10–11 Filed Mar 12
    ↗

Also filed in the last 12 months, not counted as buying or selling: 10 gifts, 10 option exercises, and 7 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
10-Q FORM 10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 3.03,5.03,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.04 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 3.03,5.03,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
DEFA14A DEFINITIVE ADDITIONAL MATERIALS Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A DEFINITIVE ADDITIONAL MATERIALS Filing Doc
10-Q FORM 10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.